Skip to content

To construct a risk prediction model for placenta accreta and adverse clinical outcomes based on clinical and MRI techniques and its application

To construct a risk prediction model for placenta accreta and adverse clinical outcomes based on clinical and MRI techniques and its application

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114000
Enrollment
Unknown
Registered
2025-12-05
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

placenta accreta spectrum (PAS) refers to the abnormal attachment or invasion of placental trophoblast cells into the myometrium due to the insufficient formation of the intermediate decidual layer. According to the depth of invasion, PAS is divided into adhesive, accreta and penetrating placenta accreta, the latter two are called invasive placenta accreta. In recent years, with the increase of ad

Interventions

Non-placenta accreta group and placenta accreta group:None

Sponsors

Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. There were no contraindications to MRI examination in patients who could cooperate with placenta MRI examination; 2.complete prenatal MRI, surgical and/or pathological data were available.

Exclusion criteria

Exclusion criteria: 1. fetal malformation; 2. poor MRI image quality; 3. patients with incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
Placental Location;Disappearance of Hypointense Signal Line on T2WI;T2WI low-signal band within the placenta;Thinning of the uterine muscle layer;Interruption of the bladder wall;Localized exophytic mass;Placental bed abnormal blood vessels;

Countries

China

Contacts

Public ContactJinlian Che

Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region

chejinlian@126.com+86 771 2860702

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026